Author

Ming-Qiang Su

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

FOXD1 upregulates DARS2-mediated glycolysis to drive cisplatin resistance in bladder cancer.

These findings identify the FOXD1/β-catenin/DARS2 axis as a potential therapeutic target for overcoming cisplatin resistance in BLCA clinically and promote cisplatin resistance in BLCA.

Xian-Yong Li, Ming-Qiang Su, Jing-Xian Luo et al. · Urologic oncology · 0 citations